European Archives - Page 29 of 1145 - European Medical Journal

mCRPC Evolving Treatment Landscape

This is a non-promotional medical symposium funded and organised by Bayer. This presentation contains information on products, indications or combinations that are not licensed in all countries, or not licensed in any region. Please consult your local prescribing information for more information. This content is intended for healthcare professionals only.

Food Addiction and Taste Bud Rehab: Interview with David Katz

David Katz | Chief Medical Officer, Tangelo, Intend; Founder/CEO, DietID, Detroit, Michigan, USA. What initially sparked your interest in…

5 minutes with... Andrew Cooper, CEO, CluePoints

Discover Andrew Cooper’s passion for optimising clinical trials with AI, driving innovation and building a culture of teamwork and purpose.

Invasive E. coli Disease Risk After Urological Procedures

The study aimed to assess the risk of IED following urologic procedures with or without antibiotic prophylaxis.

New Muscle Reference Values Improve Sarcopenia Screening

Researchers have established standardised global cutoffs for skeletal muscle index and density on abdominal CT in healthy young adults, aiding early sarcopenia detection.

Armoured CAR T-Cell Therapy Shows Promise in Resistant Lymphoma

A novel form of CAR T-cell therapy, engineered to enhance immune response, is showing encouraging results in patients with relapsed or refractory lymphoma who previously failed anti-CD19 CAR T-cell treatment.

Joan Carles

Onc Now: Episode 17: Breaking New Ground in Genitourinary Cancer Treatment

Joan Carles, Vall d’Hebron, shares insights on anti-angiogenic therapies, resistance in GU cancers, and the future of personalised oncology.

Mental Health Decline Observed in Metabolic Disease Patients Post-Pandemic

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

New Immune Therapy Effective in Acute Lymphoblastic Leukaemia

A novel CAR T cell therapy has shown encouraging results in children and adults with relapsed/refractory B-cell acute lymphoblastic leukaemia.

ESCMID Global 2025 Interview: F-Xavier Lescure

The quality of the response depends on the quality of the preparedness phase, particularly today, when we are living in a chronic and…